Ignite Creation Date:
2025-12-26 @ 2:38 PM
Ignite Modification Date:
2025-12-29 @ 11:43 AM
Study NCT ID:
NCT05281406
Status:
RECRUITING
Last Update Posted:
2025-02-21
First Post:
2022-02-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG)
Sponsor:
Goethe University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-12
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-01
First Submit QC Date:
None
Study First Post Date:
2022-03-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-20
Last Update Post Date:
2025-02-21
Last Update Post Date Type:
ACTUAL